# PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

> **NCT02448576** · NA · UNKNOWN · sponsor: **wang shusen** · enrollment: 326 (estimated)

## Conditions studied

- Breast Cancer
- Brain Metastasis

## Interventions

- **RADIATION:** prophylactic cranial irradiation

## Key facts

- **NCT ID:** NCT02448576
- **Lead sponsor:** wang shusen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 326 (ESTIMATED)
- **Last updated:** 2017-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448576, "PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02448576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*